---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-287569"
form_type: "8-K/A"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2021-09-30T23:59:59+00:00"
generated_at: "2026-06-29T00:22:55.636872+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics corrects option grant details for new CFO Maestas

## Summary
- Nicholas Maestas appointed VP, Strategy & Finance and principal financial officer effective July 12, 2021.
- Annual base salary of $325,000 with target performance bonus of 30% of base salary.
- Option to purchase 23,225 shares at July 12 closing price; vesting: 25% after one year then monthly over 36 months.
- This amendment corrects a clerical error in the original 8-K regarding the option grant terms.

## SEC filing metadata
- accession: 0001193125-21-287569
- form_type: 8-K/A
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2021-09-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312521287569/0001193125-21-287569-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312521287569/d238646d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-287569
- JSON: https://secwatch.observer/filing/0001193125-21-287569.json
- Plain text: https://secwatch.observer/filing/0001193125-21-287569.txt

## Key facts
- Executive change
  Nicholas Maestas was appointed as vice president, strategy and finance and principal financial officer at Tempest Therapeutics, Inc..
  - Action: appointed
  - Role: vice president, strategy and finance and principal financial officer
  source text: On July 12, 2021, Nicholas Maestas, age 41, joined the Company as vice president, strategy and finance and is the Company’s principal financial officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312521287569/0001193125-21-287569-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.